Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by besttobeon Mar 04, 2023 11:19am
91 Views
Post# 35319215

RE:Guidance for Q123 2.5% organic growth! low growth&margins

RE:Guidance for Q123 2.5% organic growth! low growth&marginsPrime example of company with higher revenues and less profit. See highlighted areas for pre covid and as of today data. Shrinking EPS even with buy back of shares. Not a good sign and part of the reason the stock price tanked. Thanks ISFCA for providing the table....

$US

Revenue

Covid Revenue

ebitda

ebitda/sh

Net income

Eps

2022

138,832

2,278

30,019

0.75

6,222

0.16

2021

117,062

8,558

29,283

0.72

9,126

0.22

2020

131,309

34,379

41,334

1.02

31,530

0.78

2019

80,256

0

19,034

0.48

8,525

0.21

2018

64,464

0

16,541

0.42

9,508

0.24



<< Previous
Bullboard Posts
Next >>